Implant and method for producing the same

Patent metadata

Field	Value
Publication number	US-9480779-B2
Application number	US-201113164179-A
Country	US
Kind code	B2
Filing date	Jun 20, 2011
Priority date	Jun 28, 2010
Publication date	Nov 1, 2016
Grant date	Nov 1, 2016

Abstract

The present invention relates to an implant, in particular an intraluminal endoprosthesis, the body of which comprises at least predominantly a material with iron as the main constituent. For accelerating the degradation, the material comprises sulfur as first minor constituent with a concentration of more than 0.2% by weight and not more than 1% by weight, preferably not more than 0.5% by weight, and comprises as second minor constituent at least one element of the group which comprises calcium, manganese and magnesium. Furthermore, a method for producing such an implant is described.

First claim

What is claimed is:

1. An implant, the body of which comprises a uniform degradation rate through the entire volume of the body when implanted, the body formed from at least predominantly a material comprising:
iron as a main constituent;
sulfur as first minor constituent with at a concentration of more than 0.2% by weight and not more than 1% by weight;
a second minor constituent of at least one element selected from the group consisting of calcium, manganese and magnesium, characterized in that when the second minor constituent is calcium, the calcium is at least 0.1% by weight and not more than 1% by weight, when the second minor constituent is manganese, the manganese is at least 0.5% by weight and not more than 3% by weight, and when the second minor constituent is magnesium, the magnesium is at least 0.3% by weight and not more than 1% by weight;
oxygen at a concentration of 0.05% by weight and not more than 2% by weight;
phosphorous at a concentration of 0.05% by weight and not more than 0.5% by weight;
carbon at a concentration of 0.1% by weight and not more than 0.5% by weight; and
chromium as another minor constituent with a concentration of 1% by weight, wherein the sulfides and chromium form inner local elements.

2. The implant according to claim 1 , further characterized in that calcium is more than 0.2% by weight and not more than 0.5% by weight.

3. The implant according to claim 1 , characterized in that the material of the implant body comprises predominantly iron, with a concentration of more than 80% by weight.

4. The implant according to claim 1 , characterized in that the material of the implant contains in addition at least one element selected from the group consisting of vanadium, silicon, cerium, molybdenum, titanium, tungsten and zirconium.

5. The implant according to claim 4 , characterized in that
a concentration of vanadium is at least 0.1% by weight and not more than 0.5% by weight; and/or
a concentration of silicon is at least 0.05% by weight and not more than 0.5% by weight.

6. The implant according to claim 1 in a form of an intraluminal endoprosthesis.

7. The implant according to claim 3 , characterized in that the iron is at a concentration of more than 90% by weight.

8. The implant according to claim 1 , characterized in that the oxygen is at a concentration of 0.05% by weight to 0.9% by weight.

9. The implant according to claim 5 , characterized in that
the carbon is not more than 0.3% by weight; and/or
the phosphorous is not more than 0.3% by weight; and/or
the vanadium is not more than 0.2% by weight; and/or
the silicon is not more than 0.3% by weight.

10. An implant, the body of which comprises a uniform degradation rate through the entire volume of the body when implanted, the body formed from at least predominantly a material comprising:
iron as a main constituent;
sulfur as first minor constituent with at a concentration of more than 0.2% by weight and not more than 1% by weight;
a second minor constituent of at least one element selected from the group consisting of calcium, manganese and magnesium, characterized in that when the second minor constituent is calcium, the calcium is at least 0.1% by weight and not more than 1% by weight, when the second minor constituent is manganese, the manganese is at least 0.5% by weight and not more than 3% by weight, and when the second minor constituent is magnesium, the magnesium is at least 0.3% by weight and not more than 1% by weight;
oxygen at a concentration of 0.05% by weight and not more than 2% by weight;
phosphorous at a concentration of 0.05% by weight and not more than 0.5% by weight;
carbon at a concentration of 0.1% by weight and not more than 0.5% by weight; and
cerium at a concentration of least 0.05% by weight and not more than 0.5% by weight.

11. The implant according to claim 10 , further characterized in that calcium is more than 0.2% by weight and not more than 0.5% by weight.

12. The implant according to claim 10 , characterized in that the material of the implant body comprises predominantly iron, with a concentration of more than 80% by weight.

13. The implant according to claim 12 , further characterized in that the iron is at a concentration of more than 90% by weight.

14. The implant according to claim 10 , characterized in that the material of the implant contains in addition at least one element selected from the group consisting of vanadium, silicon, cerium, molybdenum, titanium, tungsten and zirconium.

15. The implant according to claim 14 , further characterized in that a concentration of vanadium is at least 0.1% by weight and not more than 0.5% by weight; or a concentration of silicon is at least 0.05% by weight and not more than 0.5% by weight.

16. The implant according to claim 15 , characterized in that
the carbon is not more than 0.3% by weight; and/or
the phosphorous is not more than 0.3% by weight; and/or
the vanadium is not more than 0.2% by weight; and/or
the silicon is not more than 0.3% by weight.

17. The implant according to claim 10 in a form of an intraluminal endoprosthesis.

Assignees

• Bayer Ullrich
• Biotronik Ag

Inventors

• Bayer Ullrich

Classifications

• C21D8/06

  during manufacturing of rods or wires · CPC title

• C22C38/60

  containing lead, selenium, tellurium, or antimony, or more than 0.04% by weight of sulfur · CPC title

• C22C38/38

  with more than 1.5% by weight of manganese · CPC title

• C22C38/24

  with vanadium · CPC title

• C22C38/002

  containing In, Mg, or other elements not provided for in one single group C22C38/001 - C22C38/60 · CPC title